The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 19, 2017
Filed:
Nov. 20, 2013
Applicant:
Janssen Biotech, Inc., Horsham, PA (US);
Inventors:
Janet Davis, Raritan, NJ (US);
Jiajian Liu, Princeton, NJ (US);
Assignee:
Janssen Biotech, Inc., Horsham, PA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/00 (2006.01); C12N 5/02 (2006.01); C12N 5/08 (2006.01); C12N 5/071 (2010.01); C12N 5/0735 (2010.01);
U.S. Cl.
CPC ...
C12N 5/0676 (2013.01); C12N 5/0606 (2013.01); A61K 31/00 (2013.01); C12N 2501/105 (2013.01); C12N 2501/115 (2013.01); C12N 2501/117 (2013.01); C12N 2501/119 (2013.01); C12N 2501/16 (2013.01); C12N 2501/415 (2013.01); C12N 2501/48 (2013.01); C12N 2501/70 (2013.01); C12N 2506/00 (2013.01); C12N 2506/02 (2013.01);
Abstract
The present invention is provides a method for treating human pluripotent cells. In particular, the methods of the invention are directed to the treatment of human pluripotent cells, whereby the human pluripotent cells can be efficiently expanded in culture and differentiated by treating the pluripotent cells with an inhibitor of glycogen synthase kinase 3β (GSK-3B) enzyme activity.